This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Diabetes, insulin treatment (Kela reimbursement)
KELA_DIAB_INSUL
No definition available.
Endpoint definition
↥
FinnGen phenotype data
429209 individuals
Apply sex-specific rule None
429209
Check conditions None
429209
Check pre-conditions, main-only, mode, registry filters
KELA reimbursements: KELA codes
103
1 out of 7 registries used, show all original rules.
64657
Check minimum number of events None
64657
Include endpoints None
64657
Remove individuals based on genotype QC
62366
KELA_DIAB_INSUL
Control definitions
Controls for this endpoint are individuals that are not cases.
Extra metadata
First used in FinnGen datafreeze
DF2
Show upset plot detailing case counts by codes
Or the full data table
Similar endpoints
↥List of similar endpoints to
Diabetes, insulin treatment (Kela reimbursement)
based on the number of shared cases.
Broader endpoints:
- Diabetes, insulin treatment (Kela reimbursement) (more control exclusions)
- Any reimbursement code in KELA
Narrower endpoints:
Summary Statistics
↥Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 62366 | 27284 | 35082 |
| Unadjusted prevalence (%) | 15.14 | 11.85 | 19.30 |
| Mean age at first event (years) | 55.42 | 54.34 | 56.26 |
Mortality
Not a core endpoint, no data to show.
Age distribution of first events
Year distribution of first events
Cumulative Incidence
Not a core endpoint, no data to show.
Correlations
↥
Index endpoint: KELA_DIAB_INSUL – Diabetes, insulin treatment (Kela reimbursement)
GWS hits:
Survival analyses between endpoints
↥Not a core endpoint, no data to show.
Drugs most likely to be purchased after Diabetes, insulin treatment (Kela reimbursement)
↥Endpoint not on priority list, no data to show.